ScoreWhy is Arrowhead Pharmaceuticals, Inc. ?
1
The company has declared negative results in Mar'2026 after 2 consecutive positive quarters
- NET SALES(Q) At USD 73.74 MM has Fallen at -72.96%
- PRE-TAX PROFIT(Q) At USD -137.56 MM has Fallen at -315.86%
- NET PROFIT(Q) At USD -132.73 MM has Fallen at -362.49%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 435.25%, its profits have risen by 136% ; the PEG ratio of the company is 0.3
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Arrowhead Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Arrowhead Pharmaceuticals, Inc.
415.15%
3.61
64.90%
S&P 500
22.24%
1.91
13.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
68.70%
EBIT Growth (5y)
36.13%
EBIT to Interest (avg)
-57.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.36
Tax Ratio
1.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
95.16%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
14.23
EV to EBIT
25.82
EV to EBITDA
23.83
EV to Capital Employed
32.68
EV to Sales
7.11
PEG Ratio
0.26
Dividend Yield
NA
ROCE (Latest)
126.58%
ROE (Latest)
41.09%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET SALES(9M)
Higher at USD 594.24 MM
NET PROFIT(9M)
Higher at USD -125.67 MM
CASH AND EQV(HY)
Highest at USD 2,700.7 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -66.91 %
-22What is not working for the Company
NET SALES(Q)
At USD 73.74 MM has Fallen at -72.96%
PRE-TAX PROFIT(Q)
At USD -137.56 MM has Fallen at -315.86%
NET PROFIT(Q)
At USD -132.73 MM has Fallen at -362.49%
RAW MATERIAL COST(Y)
Grown by 7.68% (YoY
Here's what is working for Arrowhead Pharmaceuticals, Inc.
Cash and Eqv
Highest at USD 2,700.7 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -66.91 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Arrowhead Pharmaceuticals, Inc.
Net Sales
At USD 73.74 MM has Fallen at -72.96%
over average net sales of the previous four periods of USD 272.75 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -137.56 MM has Fallen at -315.86%
over average net sales of the previous four periods of USD 63.73 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -132.73 MM has Fallen at -362.49%
over average net sales of the previous four periods of USD 50.57 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Raw Material Cost
Grown by 7.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
